© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Health and Biotech

Top Section/Ad

Top Section/Ad

Most recent


Calendar quirk could keep issuance going in December
◆ Praemia refis at a tighter coupon ◆ Schneider lands tight at the short end ◆ Minimal concessions needed
French biotech seeks to accelerate cancer vaccine program
◆ Single digit premiums offered ◆ Reverse Yankees dominating euro supply ◆ Floaters proving popular with multi-tranche issuers
More articles/Ad

More articles/Ad

More articles

  • SSA
    CPPIB Capital came to market for a dollar benchmark on Wednesday, after mandating the deal last Friday. The trade had been postponed to avoid printing in the peak of the volatility sparked by the worsening Covid-19 outbreak.
  • Europe's high grade loan bankers are expecting better things from the second quarter of the year, citing the resolution of a handful of macro events. But the rise of the Covid-19 coronavirus is hammering markets again on Wednesday, which has the potential to put companies off raising loan debt until the second half of the year.
  • FIG
    Banks are delaying their plans to raise funding in the euro market, as credit spreads drifted wider on news about the spread of the Covid-19 coronavirus.
  • The spread of the Covid-19 coronavirus outbreak is grounding equity capital markets banks attempting to win business as face-to-face meetings are cancelled. This week SIA, the Italian payments company, said that banks pitching to win the mandate for its IPO could do so over the phone or by video call rather than travel to Milan.
  • Some of the most powerful organs of the Chinese government are doing their best to calm nerves in the domestic bond market. Local governments once again voiced their support for widespread bond issuance this week, while the central bank tried to convince investors not to fret over default risk. Addison Gong reports.
  • The emerging markets bond business, like much of the rest of the primary markets, hit a stumbling block this week due to the spread of the Covid-19 coronavirus. But even if no deals print, delaying the marketing of deals does not make sense. Roadshows should be rolling on — as Belarus is doing — even if deal printing pauses.